Endocrinology News and Research

Latest Endocrinology News and Research

Takeda Pharmaceutical's $2.37 billion settlement over Actos drug moves forward

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Takeda Pharmaceutical Co.'s $2.37 billion settlement over their diabetes drug Actos is going through and moving forward. Actos drug maker, Takeda, agreed to toss in another $100 million if enough claimants signed up with matching settlement criteria – 97% of the claims to be exact.

21 Sep 2015

Novel nebuliser could one day deliver life-saving cancer drugs

A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.

21 Sep 2015

NAMS recognizes outstanding contributions to the field of women's health, menopause

The North American Menopause Society is pleased to announce the recipients of the Society's 2015 awards that recognize outstanding contributions to the field of women's health and menopause. The recipients will be acknowledged during the NAMS 26th Annual Meeting, in Las Vegas, NV, from September 30 through October 3, 2015.

21 Sep 2015

Aggressive blood pressure treatment can reduce risks of heart disease and death

Loyola University Chicago is among the centers participating in a landmark clinical trial that has found that more intensive management of high blood pressure reduces heart disease rates and saves lives.

21 Sep 2015

New study highlights gap in scientific knowledge about some diabetes drugs

A gap in scientific knowledge about a family of drugs that are used to treat Type 2 diabetes has been highlighted in a new study.

21 Sep 2015

New study finds link between maternal protein deficiency during pregnancy and metabolic diseases in offspring

A new study has uncovered the genetic processes that link insufficient protein consumption during pregnancy with the development of muscle problems in mothers and their male offspring.

19 Sep 2015

Discovery may lead to potential treatment strategies for type 2 diabetes

Insensitivity to insulin, also called insulin resistance, is associated with type 2 diabetes and affects several cell types and organs in the body. Now, scientists from Sweden's Karolinska Institutet have discovered a mechanism that explains how insulin-producing cells can be insulin resistant and insulin sensitive at the same time.

18 Sep 2015

Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes

New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.

18 Sep 2015

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced a national specimen-draw agreement with Quest Diagnostics DGX, +1.23% the world's leading provider of diagnostic information services, that will expand patient and clinician access to the Corus CAD lab-developed blood test for aiding the assessment of obstructive coronary artery disease (CAD).

From Quest Diagnostics 18 Sep 2015

Health care disparities continue to persist in Washington state

The Washington Health Alliance released today a new report revealing disparities in how health care is delivered across race, ethnicity and language. Findings reveal that disparities in care are a continuing problem in Washington state. The report, the third of its kind that the Alliance has released, relies upon Medicaid data covering more than 680,000 enrollees.

17 Sep 2015

Winners of Renal Support Network's 13th Annual Essay Contest announced

Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.

16 Sep 2015

World Scientific's latest book to be launched on Stem Cell Awareness Day

While the world knows the $3 billion California Institute for Regenerative Medicine sprang from the citizen's initiative, Proposition 71, few people know the struggle required, nor what happened after California said "Yes!"

16 Sep 2015

Researchers use new synthetic method to prepare potential drug candidates for type 2 diabetes

Aryl alkyl ethers are important structural motifs found in many biologically active compounds. Therefore, stereoselective etherification is a highly important synthetic operation in the preparation of drug candidates.

16 Sep 2015

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.

16 Sep 2015

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).

16 Sep 2015

PHE-led study shows England has huge opportunity for lowest disease burden, preventive public health

For the first time, a new PHE led study published in The Lancet ranks the diseases and risk factors that cause death and disability in England compared with other high-income countries, revealing the nation’s potential to have the lowest total disease burden (years of life lost to death and lived with disability) in the world.

16 Sep 2015

GENFIT develops reliable, non-invasive diagnostic tool for NASH patients

GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.

16 Sep 2015

Endocrinology News and Research

Latest Endocrinology News and Research

Takeda Pharmaceutical's $2.37 billion settlement over Actos drug moves forward

Novel nebuliser could one day deliver life-saving cancer drugs

NAMS recognizes outstanding contributions to the field of women's health, menopause

Aggressive blood pressure treatment can reduce risks of heart disease and death

New study highlights gap in scientific knowledge about some diabetes drugs

New study finds link between maternal protein deficiency during pregnancy and metabolic diseases in offspring

Discovery may lead to potential treatment strategies for type 2 diabetes

Obese patients with type 2 diabetes should be prioritised for obesity surgery over those without diabetes

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

Health care disparities continue to persist in Washington state

Winners of Renal Support Network's 13th Annual Essay Contest announced

World Scientific's latest book to be launched on Stem Cell Awareness Day

Researchers use new synthetic method to prepare potential drug candidates for type 2 diabetes

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

PHE-led study shows England has huge opportunity for lowest disease burden, preventive public health

GENFIT develops reliable, non-invasive diagnostic tool for NASH patients

New computational model may help overcome misalignment of U.S. biomedical research resources

Florida Institute finalizes funding agreement with MYOLYN

Genetic basis for height and body mass differences found between European populations

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Endocrinology News and Research

Latest Endocrinology News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in